Trials / Terminated
TerminatedNCT01720056
Verapamil vs Steroid to Prevent Keloid Recurrence
Assessment of Verapamil as an Adjunct for Prevention of Keloid Recurrence After Surgical Removal
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- The University of Western Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Keloid scarring is a severe cosmetic and painful disease of the skin. The gold standard treatment is yet to be clarified. This randomized clinical pilot study will compare the effects of two local treatments for preventing keloid recurrence after surgical removal; steroid and verapamil. Study hypothesis: Intralesional therapy with the calcium antagonist verapamil has equal treatment efficacy as steroid injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Verapamil | |
| DRUG | Kenalog 10 |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2012-11-01
- Last updated
- 2015-06-10
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01720056. Inclusion in this directory is not an endorsement.